Tuesday, September 29

Healthcare

Vor Bio stock rallies post-market on trem-cel study data

09/06/20241 Min Read

Bio data postmarket rallies stock study tremcel Vor

Previous ArticleaTyr started at buy by Jefferies, citing efzofitimod potential

Next Article Ascendis raised to outperform by Oppenheimer ahead of drug launch